170 related articles for article (PubMed ID: 6421595)
1. Serum lipids and apolipoproteins A-I, A-II and B in primary hypothyroidism before and during treatment.
Muls E; Rosseneu M; Blaton V; Lesaffre E; Lamberigts G; de Moor P
Eur J Clin Invest; 1984 Feb; 14(1):12-5. PubMed ID: 6421595
[TBL] [Abstract][Full Text] [Related]
2. Serum lipids and apolipoproteins A-I, A-II, and B in hyperthyroidism before and after treatment.
Muls E; Blaton V; Rosseneu M; Lesaffre E; Lamberigts G; De Moor P
J Clin Endocrinol Metab; 1982 Sep; 55(3):459-64. PubMed ID: 6808006
[TBL] [Abstract][Full Text] [Related]
3. Changes in the distribution and composition of high-density lipoproteins in primary hypothyroidism.
Muls E; Rosseneu M; Lamberigts G; De Moor P
Metabolism; 1985 Apr; 34(4):345-53. PubMed ID: 3920475
[TBL] [Abstract][Full Text] [Related]
4. [Clinical studies on lipid metabolism in hyperthyroidism and hypothyroidism--evaluation of serum apolipoprotein levels before and after treatment].
Oribe H
Nihon Naibunpi Gakkai Zasshi; 1989 Aug; 65(8):781-93. PubMed ID: 2509259
[TBL] [Abstract][Full Text] [Related]
5. Elevated serum lipoprotein(a) in subclinical hypothyroidism.
Kung AW; Pang RW; Janus ED
Clin Endocrinol (Oxf); 1995 Oct; 43(4):445-9. PubMed ID: 7586619
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of lipoproteins and apolipoproteins in congenital hypothyroidism: effects of L-thyroxine substitution therapy.
Barbagallo CM; Averna MR; Liotta A; La Grutta S; Maggio C; Casimiro L; Cefalù AB; Notarbartolo A
Metabolism; 1995 Oct; 44(10):1283-7. PubMed ID: 7476285
[TBL] [Abstract][Full Text] [Related]
7. Increased oxidizability of low-density lipoproteins in hypothyroidism.
Diekman T; Demacker PN; Kastelein JJ; Stalenhoef AF; Wiersinga WM
J Clin Endocrinol Metab; 1998 May; 83(5):1752-5. PubMed ID: 9589687
[TBL] [Abstract][Full Text] [Related]
8. Lipid and apoprotein modifications in body builders during and after self-administration of anabolic steroids.
Baldo-Enzi G; Giada F; Zuliani G; Baroni L; Vitale E; Enzi G; Magnanini P; Fellin R
Metabolism; 1990 Feb; 39(2):203-8. PubMed ID: 2105436
[TBL] [Abstract][Full Text] [Related]
9. The effect of the treatment of hypothyroidism and hyperthyroidism on plasma lipids and apolipoproteins AI, AII and E.
O'Brien T; Katz K; Hodge D; Nguyen TT; Kottke BA; Hay ID
Clin Endocrinol (Oxf); 1997 Jan; 46(1):17-20. PubMed ID: 9059553
[TBL] [Abstract][Full Text] [Related]
10. Time-course of alterations of high density lipoproteins (HDL) during thyroxine administration to hypothyroid women.
Verdugo C; Perrot L; Ponsin G; Valentin C; Berthezene F
Eur J Clin Invest; 1987 Aug; 17(4):313-6. PubMed ID: 3117568
[TBL] [Abstract][Full Text] [Related]
11. Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromsø Study.
Iqbal A; Jorde R; Figenschau Y
J Intern Med; 2006 Jul; 260(1):53-61. PubMed ID: 16789979
[TBL] [Abstract][Full Text] [Related]
12. Changes in serum lipoprotein(a) and lipids during treatment of hyperthyroidism.
Kung AW; Pang RW; Lauder I; Lam KS; Janus ED
Clin Chem; 1995 Feb; 41(2):226-31. PubMed ID: 7874776
[TBL] [Abstract][Full Text] [Related]
13. Metabolic effects of a biphasic oral contraceptive preparation containing ethinyloestradiol and desogestrel on serum lipoproteins and apolipoproteins.
Voorhoof L; Rosseneu M; Caster H; De Keersgieter W
J Endocrinol; 1986 Oct; 111(1):191-6. PubMed ID: 2946795
[TBL] [Abstract][Full Text] [Related]
14. Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).
Hartgens F; Rietjens G; Keizer HA; Kuipers H; Wolffenbuttel BH
Br J Sports Med; 2004 Jun; 38(3):253-9. PubMed ID: 15155420
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein and apolipoprotein levels in subclinical hypothyroidism. Effect of levothyroxine therapy.
Arem R; Patsch W
Arch Intern Med; 1990 Oct; 150(10):2097-100. PubMed ID: 2222095
[TBL] [Abstract][Full Text] [Related]
16. Preliminary report: kinetic studies on the modulation of high-density lipoprotein, apolipoprotein, and subfraction metabolism by sex steroids in a postmenopausal woman.
Hazzard WR; Haffner SM; Kushwaha RS; Applebaum-Bowden D; Foster DM
Metabolism; 1984 Sep; 33(9):779-84. PubMed ID: 6433146
[TBL] [Abstract][Full Text] [Related]
17. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
[TBL] [Abstract][Full Text] [Related]
18. Decreased HDL2 and HDL3 cholesterol, Apo A-I and Apo A-II, and increased risk of myocardial infarction.
Buring JE; O'Connor GT; Goldhaber SZ; Rosner B; Herbert PN; Blum CB; Breslow JL; Hennekens CH
Circulation; 1992 Jan; 85(1):22-9. PubMed ID: 1728453
[TBL] [Abstract][Full Text] [Related]
19. Effect of levo-thyroxine replacement on non-high-density lipoprotein cholesterol in hypothyroid patients.
Ito M; Arishima T; Kudo T; Nishihara E; Ohye H; Kubota S; Fukata S; Amino N; Kuma K; Sasaki I; Hiraiwa T; Hanafusa T; Takamatsu J; Miyauchi A
J Clin Endocrinol Metab; 2007 Feb; 92(2):608-11. PubMed ID: 17148561
[TBL] [Abstract][Full Text] [Related]
20. Effect of cholesterol feeding on apo B and apo E concentrations and distributions in euthyroid and hypothyroid rats.
DeLamatre JG; Roheim PS
J Lipid Res; 1981 Feb; 22(2):297-306. PubMed ID: 7240959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
